| Andrea Caballero, MD | |
|
3220 Providence Dr Ste E3-080, Anchorage, AK 99508-4657 | |
| (907) 375-8785 | |
| (907) 375-8788 |
| Full Name | Andrea Caballero |
|---|---|
| Gender | Female |
| Speciality | Infectious Disease |
| Experience | 12 Years |
| Location | 3220 Providence Dr Ste E3-080, Anchorage, Alaska |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003173824 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | 123472 (Alaska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence Alaska Medical Center | Anchorage, AK | Hospital |
| Entity Name | Caballero Kobzoff Md Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154983294 PECOS PAC ID: 4082047683 Enrollment ID: O20191212002883 |
News Archive
Alivio Therapeutics, an affiliate of PureTech Health plc developing therapies to treat inflammatory disorders through targeted disease immunomodulation, today announced a $3.3 million U.S. Department of Defense Technology/Therapeutic Development Award to advance Alivio's product candidate, ALV-107, for the treatment of interstitial cystitis/bladder pain syndrome with Hunner's lesions.
A meta-analysis of approximately 80,000 individuals from 32 prospective studies was published in The Lancet on May 1, 2010. The data shows that elevated levels of lipoprotein-associated phospholipase A2 (Lp-PLA2), a vascular-specific inflammatory enzyme, are associated with an increased risk of coronary heart disease similar in magnitude to that with non-HDL cholesterol or systolic blood pressure.
A team of researchers who have pioneered novel treatments for post-traumatic stress disorder (PTSD) has been awarded an $11 million, four-year grant from the U.S. Department of Defense to investigate the differences between virtual reality and traditional prolonged exposure therapy.
The Ontario Pharmacists' Association today expressed concerns and disappointment with the Ontario government's announcement that it is moving ahead with regulatory changes that will significantly reduce support to Ontario pharmacists and their patients.
A latest UK study has found that deficiency of adequate sleep in children could be linked to their risk of developing diabetes later in life. The study notes that every extra hour of sleep a child gets per night is associated with a lower body weight and increased lean muscle mass and less blood sugar. The study is published this week in the journal Pediatrics.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Andrea Caballero, MD 3220 Providence Dr Ste E3-080, Anchorage, AK 99508-4657 Ph: (907) 375-8785 | Andrea Caballero, MD 3220 Providence Dr Ste E3-080, Anchorage, AK 99508-4657 Ph: (907) 375-8785 |
News Archive
Alivio Therapeutics, an affiliate of PureTech Health plc developing therapies to treat inflammatory disorders through targeted disease immunomodulation, today announced a $3.3 million U.S. Department of Defense Technology/Therapeutic Development Award to advance Alivio's product candidate, ALV-107, for the treatment of interstitial cystitis/bladder pain syndrome with Hunner's lesions.
A meta-analysis of approximately 80,000 individuals from 32 prospective studies was published in The Lancet on May 1, 2010. The data shows that elevated levels of lipoprotein-associated phospholipase A2 (Lp-PLA2), a vascular-specific inflammatory enzyme, are associated with an increased risk of coronary heart disease similar in magnitude to that with non-HDL cholesterol or systolic blood pressure.
A team of researchers who have pioneered novel treatments for post-traumatic stress disorder (PTSD) has been awarded an $11 million, four-year grant from the U.S. Department of Defense to investigate the differences between virtual reality and traditional prolonged exposure therapy.
The Ontario Pharmacists' Association today expressed concerns and disappointment with the Ontario government's announcement that it is moving ahead with regulatory changes that will significantly reduce support to Ontario pharmacists and their patients.
A latest UK study has found that deficiency of adequate sleep in children could be linked to their risk of developing diabetes later in life. The study notes that every extra hour of sleep a child gets per night is associated with a lower body weight and increased lean muscle mass and less blood sugar. The study is published this week in the journal Pediatrics.
› Verified 1 days ago
Daryl M. Mcclendon, M.D., P.C. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 3851 Piper Street, Suite U466, Anchorage, AK 99508 Phone: 907-569-1333 Fax: 907-569-1433 | |
Dr. Loretta Leih-sheng Lee, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 4001 Dale St, Suite 210, Anchorage, AK 99508 Phone: 907-929-5880 Fax: 907-929-5882 | |
Dr. Richard Merle Farleigh, M.D. Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 4120 Laurel St, Suite 202, Anchorage, AK 99508 Phone: 907-561-4293 | |
Alexis Leandro Delgado, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 4300 B St, Suite 200, Anchorage, AK 99503 Phone: 907-375-3355 Fax: 907-375-3351 | |
Geronimo Sahagun, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 2841 Debarr Road, Suite 50, Anchorage, AK 99508 Phone: 907-276-2811 Fax: 907-276-2810 | |
Dr. Tram Phuong Chu, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 3200 Providence Dr, Suite B111, Anchorage, AK 99508 Phone: 907-212-7890 Fax: 907-212-2374 |